Aperçu des produits pour anti-MAP3K2 (MAP3K2) Anticorps

Full name:
anti-Mitogen-Activated Protein Kinase Kinase Kinase 2 Anticorps (MAP3K2)
Chez www.anticorps-enligne.fr sont 54 Mitogen-Activated Protein Kinase Kinase Kinase 2 (MAP3K2) Anticorps de 12 de différents fournisseurs disponibles. De plus, nous expédions MAP3K2 Protéines (7) et beaucoup plus de produits pour cette protéine. Un total de 67 MAP3K2 produits sont actuellement listés.
Synonymes:
9630061B06Rik, AI585793, MEKK2, Mekk2b
afficher tous les anticorps Gène GeneID UniProt
MAP3K2 171492  
MAP3K2 10746 Q9Y2U5
MAP3K2 26405  

Afficher toutes les espèces

Afficher tous les synonymes

Réactivités les plus populaires pour anti-MAP3K2 (MAP3K2) Anticorps

Sélectionnez vos espèces et l'application

anti-Rat (Rattus) MAP3K2 Anticorps:

anti-Human MAP3K2 Anticorps:

anti-Mouse (Murine) MAP3K2 Anticorps:

Tous anti-MAP3K2 Anticorps disponible

Vous arrivez à notre recherche pré-filtrée.

anti-MAP3K2 Anticorps mieux référencés

  1. Human Monoclonal MAP3K2 Primary Antibody pour ICC, ELISA - ABIN969272 : Kurada, Li, Mulherkar, Subramanian, Prasad, Prabhakar: MADD, a splice variant of IG20, is indispensable for MAPK activation and protection against apoptosis upon tumor necrosis factor-alpha treatment. dans The Journal of biological chemistry 2009 (PubMed)
    Show all 2 references for 969272

  2. Human Monoclonal MAP3K2 Primary Antibody pour EIA, IF - ABIN1108129 : Spathelf, Rautenbach: Anti-listerial activity and structure-activity relationships of the six major tyrocidines, cyclic decapeptides from Bacillus aneurinolyticus. dans Bioorganic & medicinal chemistry 2009 (PubMed)
    Show all 2 references for 1108129

  3. Cow (Bovine) Polyclonal MAP3K2 Primary Antibody pour WB - ABIN2783679 : Wissing, Jänsch, Nimtz, Dieterich, Hornberger, Kéri, Wehland, Daub: Proteomics analysis of protein kinases by target class-selective prefractionation and tandem mass spectrometry. dans Molecular & cellular proteomics : MCP 2007 (PubMed)

Plus d’anticorps contre MAP3K2 partenaires d’interaction

Human Mitogen-Activated Protein Kinase Kinase Kinase 2 (MAP3K2) interaction partners

  1. miR (Montrer MLXIP Anticorps)-34c-3p may regulate triple-negative breast cancer progression by directly targeting the 3'-untranslated region of mitogen-activated protein kinase kinase kinase 2 (MAP3K2).

  2. Study found miR (Montrer MLXIP Anticorps)-186 expression significantly decreased in lung cancer tissues and cells and MAP3K2 expression increased in the same cancer tissues. Also, results confirmed that MAP3K2 is a target gene of miR (Montrer MLXIP Anticorps)-186 and both expression correlated with prognosis.

  3. SMYD3 (Montrer SMYD3 Anticorps)-mediated methylation of MAP3K2 increases mutant K-Ras (Montrer HRAS Anticorps)-induced activation of ERK1/2 (Montrer MAPK1/3 Anticorps). (Review)

  4. Restoration of miR17/20a in solid tumor cells enhances the natural killer cell antitumor activity by targeting Mekk2

  5. HBXIP (Montrer HBXIP Anticorps) activated ERK1/2 (Montrer MAPK1/3 Anticorps) through up-regulating MEKK2.

  6. MEKK2 has a novel function as a regulator of ubiquitylation-dependent paxillin (Montrer PXN Anticorps) redistribution in breast tumour cells.

  7. EBV microRNA BART (Montrer BSND Anticorps) 18-5p targets MAP3K2 to facilitate persistence in vivo by inhibiting viral replication in B cells.

  8. Inhibitors of apoptosis proteins regulate myogenic differentiation by directly suppressing MEKK2/3-MEK5 (Montrer MAP2K5 Anticorps)-ERK5 (Montrer MAPK7 Anticorps) signaling.

  9. methylation of MAP3K2 by SMYD3 increases MAP kinase signalling and promotes the formation of Ras-driven carcinomas

  10. results strongly support a role for MEKK2 as a regulator of signaling that modulates breast tumor cell spread area and migration through control of focal adhesion stability

Mouse (Murine) Mitogen-Activated Protein Kinase Kinase Kinase 2 (MAP3K2) interaction partners

  1. FGF2 (Montrer FGF2 Anticorps)/MEKK2 pathway mediates an alternative nonclassical pathway for beta-catenin (Montrer CTNNB1 Anticorps) activation, and this pathway is a key regulator of bone formation by osteoblasts

  2. Stk38 (Montrer STK38 Anticorps) protein kinase (Montrer CDK7 Anticorps) has a role in inhibiting TLR9 (Montrer TLR9 Anticorps)-activated inflammatory responses by promoting MEKK2 ubiquitination in macrophages

  3. methylation of MAP3K2 by SMYD3 increases MAP kinase signalling and promotes the formation of Ras-driven carcinomas

  4. MEKK2 is regulated through a phosphorylation-dependent association with 14-3-3 (Montrer YWHAQ Anticorps), a group of adapters that modulate dimerization and association between proteins

  5. MEKK2 signaling contributes to right ventricular hypertrophy and altered myocardial inflammatory gene expression in response to hypoxia-induced pulmonary hypertension.

  6. MEKK2 alone can suppress T-cell TGF-beta (Montrer TGFB1 Anticorps) responses. MEKK2 or MEKK3 (Montrer MAP3K3 Anticorps) can cause ERK1/2 (Montrer MAPK1/3 Anticorps) to phosphorylate SMAD2 (Montrer SMAD2 Anticorps)/3 and suppress R-SMAD (Montrer SMAD1 Anticorps)-dependent transcription. MEKK2 and MEKK3 (Montrer MAP3K3 Anticorps) play overlapping roles in regulating Th-cell differentiation via TGF-beta (Montrer TGFB1 Anticorps)

  7. Data show that HDAC4 (Montrer HDAC5 Anticorps) binds and promotes the deacetylation and activation of a key MAP3 kinase, MEKK2.

  8. Data from experiments with Mekk2(-/-) mice show that MEKK2 may be required for controlling the strength of T cell receptor/CD3 (Montrer CD3E Anticorps) signaling.

  9. PB1 (Montrer GPR97 Anticorps) domain mediates the association of MEKK2 and MEKK3 (Montrer MAP3K3 Anticorps) with MEK5 (Montrer MAP2K5 Anticorps) and that the respective PB1 (Montrer GPR97 Anticorps) domains of these kinases are critical for regulation of the ERK5 (Montrer MAPK7 Anticorps) pathway.

  10. Rap1 (Montrer TERF2IP Anticorps) and MEKK2 are critical upstream signaling molecules mediating BDNF (Montrer BDNF Anticorps) stimulation of ERK5 (Montrer MAPK7 Anticorps) in central nervous system neurons

MAP3K2 profil antigène

Antigen Summary

The protein encoded by this gene is a member of serine/threonine protein kinase family. This kinase preferentially activates other kinases involved in the MAP kinase signaling pathway. This kinase has been shown to directly phosphorylate and activate Ikappa B kinases, and thus plays a role in NF-kappa B signaling pathway. This kinase has also been found to bind and activate protein kinase C-related kinase 2, which suggests its involvement in a regulated signaling process.

Alternative names and synonyms associated with MAP3K2

  • mitogen activated protein kinase kinase kinase 2 (Map3k2) anticorps
  • mitogen-activated protein kinase kinase kinase 2 (MAP3K2) anticorps
  • mitogen-activated protein kinase kinase kinase 2 (Map3k2) anticorps
  • 9630061B06Rik anticorps
  • AI585793 anticorps
  • MEKK2 anticorps
  • Mekk2b anticorps

Protein level used designations for MAP3K2

mitogen-activated protein kinase kinase kinase 2 , MAP/ERK kinase kinase 2 , MAPK/ERK kinase kinase 2 , MEK kinase 2 , MEKK 2 , mitogen activated protein kinase kinase kinase 2 , protein kinase MEKK2b

GENE ID SPECIES
171492 Rattus norvegicus
10746 Homo sapiens
26405 Mus musculus
612902 Canis lupus familiaris
100050628 Equus caballus
504592 Bos taurus
424225 Gallus gallus
100621234 Sus scrofa
Fournisseurs de qualité sélectionnés pour anti-MAP3K2 (MAP3K2) Anticorps
Avez-vous cherché autre chose?